Search Contract Opportunities

ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

ID: 36C25526N0394 • Notice Type: Award Notice • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Analyze Opportunity
Loading

Description

Background
The Department of Veterans Affairs, specifically the Network Contracting Office (NCO 15), is issuing this contract to provide a proprietary radiopharmaceutical agent, PLUVICTO, for use in the Nuclear Medicine department at the VA St. Louis Health Care System. This contract aims to support the treatment of adult patients with PSMA positive metastatic castration resistant prostate cancer who have undergone prior treatments.

Work Details
The contract includes the delivery of 26 units of PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), NDC 69488 0010 6. The unit price for each item is $34,294.26, leading to an extended total amount of $891,650.76 for the entire order. The product is intended for diagnostic and therapeutic use as outlined in the Statement of Work included in the solicitation.

Period of Performance
August 5, 2026 through February 5, 2027

Place of Performance
VA St. Louis Health Care System, John J. Cochran Veterans Hospital, 915 North Grand Boulevard, St. Louis, MO 63106

Bidder Requirements
Bidders must be authorized distributors or manufacturers of PLUVICTO and comply with all terms and conditions outlined in FSS Contract Number 36F79720D0180. Invoices must reference PO number 657-C60305 and Order number 36C25526N0394.
Ordering Activity / Contracting Office Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway Leavenworth, KS 66048 Contract / Order Information FSS Contract Number: 36F79720D0180 Order Number: 36C25526N0394 Requisition / PO Number: 657-C60305 Effective Date of Award: August 5, 2026Ordering Period: August 5, 2026 through February 5, 2027 Method of Solicitation: FSS order under SF 1449, commercial products and commercial services Awardee (Contractor) Novartis Pharmaceuticals Corporation 59 Route 10 East Hanover, NJ 07936 UEI: NG61ZA8TADW3 (as shown on the SF 1449). Primary Contractor POC: Yisell Rodriguez, 201 602 5055, yisell.rodriquez@novartis.com. Place of Delivery / Performance VA St. Louis Health Care System John J. Cochran Veterans Hospital 915 North Grand Boulevard St. Louis, MO 63106 Description of Supplies/Services This award provides one proprietary radiopharmaceutical agent, PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), NDC 69488 0010 6, for use by Nuclear Medicine at VA St. Louis Health Care System. PLUVICTO is indicated for adult patients with PSMA positive metastatic castration resistant prostate cancer who have been treated with androgen receptor pathway inhibition and taxane based chemotherapy. The period of performance supports diagnostic and therapeutic use of this radiopharmaceutical in accordance with the Statement of Work included in the SF 1449. Line Item and Pricing CLIN 0001: PLUVICTO Lutetium Lu 177 vipivotide tetraxetan, NDC 69488 0010 6. Quantity: 26 Each. Unit Price: 34,294.26. Extended Amount: 891,650.76. Total Award Amount: 891,650.76. Funding / Accounting Data As shown on SF 1449: 657 26 4 1642 0063 / 657 3660 / 160 1642 822900 2580 / 0100L00H6 (Accounting and Appropriation Data). Invoice and Payment Instructions Invoices shall be submitted monthly in arrears and must reference PO number 657 C60305 and Order number 36C25526N0394. All invoices shall be submitted electronically in accordance with VAAR 852.232 72, via the VA Financial Services Center e-invoicing system (Austin, TX). Payment will be made by: Department of Veterans Affairs Financial Services Center, Austin, TX (see SF 1449 Block 18a and Continuation Page for full details). Contract Administration / Points of Contact Contracting Officer: Michael P. Murphy Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway, Leavenworth, KS 66048 Email: michael.murphy7@va.gov Phone: 913 946 1970 Facility Point of Contact (Pluvicto): Mark Lauridsen VA St. Louis Health Care System Email: mark.lauridsen@va.gov Phone: 314 652 4100 ext. 66522 The Contracting Officer retains sole authority to approve changes or modifications affecting price, quantity, or quality of performance under this contract. The Contracting Officer s Representative (COR) will be designated separately in accordance with VAAR 852.270 1 and will be responsible for technical and administrative oversight. Special Terms and Conditions This order is subject to the terms and conditions of FSS Contract 36F79720D0180 and all clauses incorporated by reference on SF 1449, including VAAR 852.247 71 (Delivery Location), VAAR 852.232 72 (Electronic Submission of Payment Requests), VAAR 852.203 70 (Commercial Advertising), VAAR 852.242 71 (Administrative Contracting Officer), and VAAR 852.246 71 (Rejected Goods). The VA St. Louis Health Care System s business hours and applicable federal holidays are as set forth in the Statement of Work, and contract performance monitoring will be conducted in accordance with VA quality assurance procedures described therein.

Overview

Award ID
36F79720D018036C25526N0394
Reported Award
$891,650
Award Date
Posted Date
Set Aside
None
Place of Performance
Not Provided
Source

Pricing Structure
Likely Fixed Price
Current SBA Size Standard
1300 Employees
ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063 (36C25526N0394) was awarded to Novartis Pharmaceuticals Corporation on 8/21/26 by VISN 15: Heartland Network.
Primary Contact
Title
Michael Murphy
Name
Michael P Murphy   Profile
Phone
(913) 946-1963

Additional Contacts in Documents

Title Name Email Phone
Facility Point of Contact (Pluvicto) Mark Lauridsen Profile mark.lauridsen@va.gov (314) 652-4100

Documents

Posted documents for Award Notice 36C25526N0394

Opportunity Assistant


Analyze Opportunity

Award Notifications

Agency published notification of awards for Award Notice 36C25526N0394

Similar Active Opportunities

Open contract opportunities similar to Award Notice 36C25526N0394

Experts for ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > 255-NETWORK CONTRACT OFFICE 15 (36C255)
FPDS Organization Code
3600-00255
Source Organization Code
100186523
Last Updated
Last Updated By
Michael.Murphy7@va.gov
Archive Date
Original Title
6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063